{"id":"https://genegraph.clinicalgenome.org/r/4e6699a2-3699-456b-9860-bafe2b247382v1.0","type":"EvidenceStrengthAssertion","dc:description":"There is abundant evidence published associating the XPC gene with xeroderma pigmentosum group C since the gene-disease relationship was first proposed by Li et al. (1993). Multiple case level studies have been performed with XPC patients that have variants in the XPC gene. 8 complementation groups genes (XPA, XPB, XPC, XPD, XPE, XPF, XPG, and XP variant (XPV)) in Nucleotide excision repair (NER) pathway were reported to cause Xeroderma Pigmentosum. Multiple Xpc deficient mouse models have been established to show consistent phenotypes with XPC patients, including highly susceptible to ultraviolet-induced carcinogenesis and chemically-induced liver and lung tumors. All of these types of evidence are consistent with a definitive relationship between the XPC gene and xeroderma pigmentosum group C.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/4e6699a2-3699-456b-9860-bafe2b247382","GCISnapshot":"https://genegraph.clinicalgenome.org/r/8352d38c-7fb3-4a82-8f8b-7cd08fded1f4","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/8352d38c-7fb3-4a82-8f8b-7cd08fded1f4_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-01T00:00:00Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/8352d38c-7fb3-4a82-8f8b-7cd08fded1f4_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2018-11-02T21:42:21.860Z","role":"Approver"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8352d38c-7fb3-4a82-8f8b-7cd08fded1f4_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7c8f3ed-821f-4272-bfcf-7dc37e80c916_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A 2-bp deletion (1132delA) in the XPC gene, predicted to result in premature termination of the protein by a new stop codon 15 nucleotides downstream.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6d457045-8194-4fdc-ab00-483216a142db","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8298653","rdfs:label":"XP1BE-L1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0008069","obo:HP_0003079","obo:HP_0000992"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/c7c8f3ed-821f-4272-bfcf-7dc37e80c916_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8298653","allele":{"id":"https://genegraph.clinicalgenome.org/r/03afaa3e-02d1-4993-8604-dc65df3a20b7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004628.4(XPC):c.1292_1293delAA (p.Lys431Argfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/256"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/79f455f9-d2b5-4566-8df4-a70e4ee3e8b8_proband_score_evidence_line","type":"EvidenceLine","dc:description":"In 20 affected members of 14 Tunisian families with severe XPC, Ben Rekaya et al. (2009) identified a homozygous 2-bp deletion (1744delTG) in exon 9 of the XPC gene, resulting in a frameshift and premature termination (fsTer572). Haplotype analysis indicated a founder effect.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9087ac66-8c5e-490f-94b7-30fa99e84b93","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19478817","rdfs:label":"XPC32DJ","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":60,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0008069","obo:HP_0000613","obo:HP_0000992","obo:HP_0012056","obo:HP_0002860","obo:HP_0002671"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/79f455f9-d2b5-4566-8df4-a70e4ee3e8b8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19478817","allele":{"id":"https://genegraph.clinicalgenome.org/r/ec4a7120-26f0-4f38-8e62-6a6fe3ec6f06","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004628.4(XPC):c.1643_1644delTG (p.Val548Alafs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/262"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/8352d38c-7fb3-4a82-8f8b-7cd08fded1f4_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/be3e473e-f052-4614-b8c7-a994dddb0d17_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11511294","rdfs:label":"XP67TMA and XP68TMA","estimatedLodScore":4.73,"family":{"id":"https://genegraph.clinicalgenome.org/r/be3e473e-f052-4614-b8c7-a994dddb0d17","type":"Family","rdfs:label":"XP67TMA and XP68TMA","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/ea1b0590-68ad-40ff-8865-a57ed2c03848","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11511294","rdfs:label":"XP67TMA","ageType":"AgeAtDeath","ageUnit":"Years","ageValue":10,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0008069","obo:HP_0003079","obo:HP_0000992"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/324e5f25-0f23-47d1-847c-d84ac7012605_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11511294","allele":{"id":"https://genegraph.clinicalgenome.org/r/ba6884ba-3ea2-4857-b165-c993f96c99c4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004628.4(XPC):c.1735C>T (p.Arg579Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/259"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":33,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0000992","obo:HP_0003079","obo:HP_0008069"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/ea1b0590-68ad-40ff-8865-a57ed2c03848"}},{"id":"https://genegraph.clinicalgenome.org/r/5e990bd4-3e4b-407c-bf2e-75a902aa2133_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11121128","rdfs:label":"XP12TA and XP25TA","estimatedLodScore":0.98,"family":{"id":"https://genegraph.clinicalgenome.org/r/5e990bd4-3e4b-407c-bf2e-75a902aa2133","type":"Family","rdfs:label":"XP12TA and XP25TA","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/708e22d7-4104-42eb-839e-d226d4247a8e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11121128","rdfs:label":"XP12TA","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":3,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0003079","obo:HP_0008069","obo:HP_0000992"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/873ad777-6cd6-47a8-ab84-422a1b501a94_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11121128","allele":{"id":"https://genegraph.clinicalgenome.org/r/717b03f0-a486-421b-a244-7ef1449ce1c0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004628.4(XPC):c.566_567delAT (p.Tyr189Serfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/258"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":3,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0003079","obo:HP_0008069","obo:HP_0000992"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/708e22d7-4104-42eb-839e-d226d4247a8e"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/324e5f25-0f23-47d1-847c-d84ac7012605_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A 1840C-T transition in exon 8 of the XPC gene, resulting in an arg579-to-ter (R579X) substitution. This mutation was reported by Chavanne et al. (2000) in an Italian patient (XP10PV) from Bologna who developed skin cancers beginning at age 4 years.  Gozukara et al. (2001) studied 19 microsatellite markers flanking the XPC gene on chromosome 3; their results suggested that the XPC allele passed between Italy and Turkey approximately 300 to 500 years ago.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ea1b0590-68ad-40ff-8865-a57ed2c03848"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/4f6b5642-1ac2-4ccf-9080-c42ab2960df7_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The XP1MI cell line was the most UV-sensitive of 5 cell lines analyzed by Li et al. (1993). Furthermore, the patient demonstrated XP-associated neurologic abnormalities, a rarity in group C. But no direct support from functional evidence.","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/74612eec-3be9-4cb1-8475-a5c9e3d6bf2e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8298653","rdfs:label":"XP1MI","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0000992","obo:HP_0003079","obo:HP_0008069"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/4f6b5642-1ac2-4ccf-9080-c42ab2960df7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8298653","allele":{"id":"https://genegraph.clinicalgenome.org/r/5390c9e7-2c41-48ca-ba4c-a98e93935a55","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004628.4(XPC):c.1001C>A (p.Pro334His)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/253"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/873ad777-6cd6-47a8-ab84-422a1b501a94_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A homozygous 2-bp deletion (669delAT) in exon 5 of the XPC gene predicted to result in a truncated protein. Northern blot analysis revealed greatly reduced xeroderma pigmentosum complementation group C mRNA. This is a two star variant in ClinVar.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/708e22d7-4104-42eb-839e-d226d4247a8e"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/529a1232-ee21-4f6d-a8d8-60f6dc6516be_proband_score_evidence_line","type":"EvidenceLine","dc:description":"An 83-bp insertion beginning at position 462 in the XPC cDNA, predicted to result in premature termination.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9584823a-a205-443e-9afb-b12fe15f2fe0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8298653","rdfs:label":"XP3BE-L3","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"PCR","phenotypes":["obo:HP_0000992","obo:HP_0008069","obo:HP_0003079"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/529a1232-ee21-4f6d-a8d8-60f6dc6516be_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8298653","allele":{"id":"https://genegraph.clinicalgenome.org/r/5d5f0148-e136-44af-a0c3-21e7768ada8a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_004628.4(XPC):c.621_622ins83 (p.?)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/254"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/8352d38c-7fb3-4a82-8f8b-7cd08fded1f4_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8352d38c-7fb3-4a82-8f8b-7cd08fded1f4_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6a50bb47-2b15-4787-ae63-d4f40d0c9e56","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c64742a6-e93b-41b6-9eed-37313b50a754","type":"Finding","dc:description":"Homozygous XPC-deficient mice were found to be highly susceptible to ultraviolet-induced carcinogenesis compared to mice heterozygous for the mutant allele and to wildtype controls. Homozygous mutant mice also displayed a spectrum of ultraviolet exposure-related pathologic skin and eye changes consistent with those found in the human disease xeroderma pigmentosum group C. The deficient mice showed marked hyperplasia of the epidermis with focal areas of hyperkeratosis in varying degrees of dysplasia, acantholysis, and/or dyskeratosis, similar to the human lesions known as actinic or solar keratosis.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7675084","rdfs:label":"High susceptibility to UV-induced carcinogenesis in XPC mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9c6f2ebb-f72a-4001-9ad4-4524f6e23a0f","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d680ce41-f212-41da-a3c0-a00cf7fcccd0","type":"Finding","dc:description":"They observed a significantly higher incidence of chemically-induced liver and lung tumors in XPC -/- mice, compared with normal and heterozygous littermates, using 2-acetylaminofluorene and NOH-2-acetylaminofluorene. In addition, the progression of liver tumors in the mice homozygous mutant for XPC and heterozygous mutant for p53 was accelerated, compared with the homozygous mutant XPC mice and homozygous wildtype p53 animals. They also demonstrated a higher incidence of spontaneous testicular tumors in XPC -/- p53 -/- double mutant mice, compared with mice homozygous for mutation only at the p53 locus.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10029060","rdfs:label":"XPC-/- mice treated with chemical & XPC-/- Trp53-/- mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/8352d38c-7fb3-4a82-8f8b-7cd08fded1f4_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/04a1fc30-636e-4ee4-bbac-acc14e585f3d","type":"EvidenceLine","dc:description":"Eight genes","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0838460c-b97b-4ba5-abaf-9b2a8c59242a","type":"Finding","dc:description":"8 complementation groups genes (XPA, XPB, XPC, XPD, XPE, XPF, XPG, and XP variant (XPV)) in Nucleotide excision repair (NER) pathway cause Xeroderma Pigmentosum.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24105368","rdfs:label":"8 complementation groups genes cause Xeroderma Pigmentosum","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":324,"specifiedBy":"GeneValidityCriteria6","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/GmYZyEL3cSg","type":"GeneValidityProposition","disease":"obo:MONDO_0010211","gene":"hgnc:12816","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_8352d38c-7fb3-4a82-8f8b-7cd08fded1f4-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}